{"database": "lobbying", "table": "lobbying_activities", "rows": [[478047, "79d5bc55-577c-4bac-bca8-627a9ecf61ee", "YY", "PODESTA GROUP, INC.", 31680, "NOVO NORDISK INC", 2006, "year_end", "PHA", "Drug safety and importation issues, Clinical trials.\nGenerics Biologics\nHR 328, Pharmaceuticals Market Access Act of 2005.\nHR 2090, Food and Drug Administration Improvement Act of 2005.\nS 2766, National Defense Authorization Act for Fiscal Year 2007; Drug pricing.\nS 3807, Enhancing Drug Safety and Innovation Act of 2006. \n\n\r\nHR 700, Pharmaceutical Market Access and Drug Safety Act of 2005.\nS 109, Pharmaceutical Market Access Act of 2005.\nS 334, Pharmaceutical Market Access and Drug Safety Act of 2005.\nS 930, Food and Drug Administration Safety Act of 2005.", "Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 100000, null, 0, 0, "2007-02-12T14:50:38-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["478047"], "units": {}, "query_ms": 0.5654430715367198, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}